Patents by Inventor David Rosen

David Rosen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11413327
    Abstract: A method of alleviating joint pain in a patient comprising evaluating the patient's joint pain when undergoing motions associated stress to the joint, and injecting the patient with a peptide of SEQ ID No. 1, and thereafter evaluating the patient's joint pain when undergoing the same motion.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: August 16, 2022
    Assignee: ORTHOTROPHIX, INC.
    Inventors: Yoshinari Kumagai, Dawn McGuire, Meghan Miller, David Rosen
  • Publication number: 20220239457
    Abstract: Scheduling full-duplex transmissions includes configuring adjacent time slots of an air interface resource with different ratios of uplink portions, downlink portions, and flexible portions, scheduling transmissions in each adjacent time slot based on whether or not the transmissions are latency-sensitive or delay-sensitive or control transmissions. The uplink portions, downlink portions, and flexible portions comprise symbols within time slots of a subframe, and can vary based on a numerology. The flexible portions are symbols configured to simultaneously transmit uplink data and downlink data.
    Type: Application
    Filed: April 14, 2022
    Publication date: July 28, 2022
    Inventors: Akin OZOZLU, Noman ALAM, Nagi MANSOUR, David ROSEN
  • Publication number: 20220226433
    Abstract: A diagnostic and a method of treatment are disclosed whereby the diagnostic identifies patients more likely to respond to a therapeutic intervention thereby improving clinical benefits including improved joint function, reduced pain, and other clinical symptoms.
    Type: Application
    Filed: September 27, 2021
    Publication date: July 21, 2022
    Applicant: Orthotrophix, Inc.
    Inventors: Yoshinari Kumagai, Dawn McGuire, Meghan Miller, David Rosen
  • Patent number: 11389505
    Abstract: A method of alleviating joint pain in a patient comprising evaluating the patient's joint pain when undergoing motions associated stress to the joint, and injecting the patient with a peptide of SEQ ID No. 1, and thereafter evaluating the patient's joint pain when undergoing the same motion.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: July 19, 2022
    Assignee: ORTHOTROPHIX, INC.
    Inventors: Yoshinari Kumagai, Dawn McGuire, Meghan Miller, David Rosen
  • Publication number: 20220197024
    Abstract: An optical system includes a reflective polarizer (20), and a display (10), first mirror (30a), and second mirror (30b) disposed on a same side of the reflective polarizer (20). The reflective polarizer (20) transmits an image emitted by the display (10) after the image is reflected by the first and second mirrors (30a, 30b). A mid-plane defined by intersection points between an optical axis of the system and the display (10), reflective polarizer (20), and second mirror (30b) has one-pass through four-pass regions having respective areas, A1 through A4.
    Type: Application
    Filed: June 6, 2019
    Publication date: June 23, 2022
    Inventors: Zhisheng Yun, Stephen J. Willett, Craig R. Schardt, Gilles J. Benoit, Keith M. Kotchick, Ryan C. Shirk, David A. Rosen, Hao Wu
  • Patent number: 11356234
    Abstract: Scheduling full-duplex transmissions includes configuring adjacent time slots of an air interface resource with different ratios of uplink portions, downlink portions, and flexible portions, scheduling transmissions in each adjacent time slot based on whether or not the transmissions are latency-sensitive or delay-sensitive or control transmissions. The uplink portions, downlink portions, and flexible portions comprise symbols within time slots of a subframe, and can vary based on a numerology. The flexible portions are symbols configured to simultaneously transmit uplink data and downlink data.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: June 7, 2022
    Assignee: T-Mobile Innovations LLC
    Inventors: Akin Ozozlu, Noman Alam, Nagi Mansour, David Rosen
  • Publication number: 20220119413
    Abstract: Compounds and methods in the fields of chemistry and medicine are disclosed. Some of the disclosed embodiments include compounds, compositions and methods of using heterocycle amines. Some of the disclosed embodiments include heterocycle amines useful to treat inflammatory disorders.
    Type: Application
    Filed: October 28, 2021
    Publication date: April 21, 2022
    Inventors: Koc-Kan Ho, David Diller, Jeffrey J. Letourneau, Brian F. McGuinness, Andrew G. Cole, David Rosen, Cornelis A. van Oeveren, Jason C. Pickens, Lin Zhi, Yixing Shen, Bijan Pedram
  • Publication number: 20220105154
    Abstract: Compounds, pharmaceutical compositions, and a method of treating hard tissue diseases and disorders are disclosed. The compounds may be a peptide and is structured to bind integrin ?v?3 expressed by osteocytes and by selective binding to the cell surface integrin on hard tissue forming cells regulate three-dimensional bone shape, cartilage formation and repair.
    Type: Application
    Filed: September 17, 2021
    Publication date: April 7, 2022
    Applicant: ORTHOTROPHIX, INC.
    Inventors: Yoshinari Kumagai, Dawn McGuire, Meghan Miller, David Rosen
  • Publication number: 20220047501
    Abstract: A method of treating osteoarthritis by modifying the shape change of bone(s) underlying articular cartilage, comprising evaluating the bone shape of the patient's joint, injecting the patient with a peptide of SEQ ID No. 1 or applying other therapeutic interventions that can reduce the shape change of the bone(s) underlying articular cartilage, and thereafter evaluating the bone shape of the patient's joint is disclosed.
    Type: Application
    Filed: November 2, 2021
    Publication date: February 17, 2022
    Applicant: ORTHOTROPHIX, INC.
    Inventors: Yoshinari KUMAGAI, Dawn McGUIRE, Meghan MILLER, David ROSEN
  • Patent number: 11186593
    Abstract: Compounds and methods in the fields of chemistry and medicine are disclosed. Some of the disclosed embodiments include compounds, compositions and methods of using heterocycle amines. Some of the disclosed embodiments include heterocycle amines useful to treat inflammatory disorders.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: November 30, 2021
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Koc-Kan Ho, David Diller, Jeffrey J. Letourneau, Brian F. McGuinness, Andrew G. Cole, David Rosen, Cornelis A. van Oeveren, Jason C. Pickens, Lin Zhi, Yixing Shen, Bijan Pedram
  • Publication number: 20210335333
    Abstract: A method implemented by a determination engine is provided. The determination engine receives a media dataset comprising target piece music information, target piece audience information, corpus music information, corpus audience information, and corpus preference data. The determination engine determines a subset of the corpus music and preference information and determines at least one surprise factor of the subset of the corpus music and preference information across features at one of a plurality of orders. The determination engine learns a model that estimates a likelihood that time-varying surprise trends across the features achieves a preference level. The determination engine determines at least one surprise factor of the target piece music information across the features at the one of the plurality of orders and predicts, using the model, preference information using the time-varying surprise trends for the target piece music information across the features.
    Type: Application
    Filed: July 7, 2021
    Publication date: October 28, 2021
    Applicant: Secret Chord Laboratories, Inc.
    Inventors: Scott Miles, David Rosen, Shaun Barry
  • Publication number: 20210238237
    Abstract: A method of alleviating joint pain in a patient comprising evaluating the patient's joint pain when undergoing motions associated stress to the joint, and injecting the patient with a peptide of SEQ ID No. 1, and thereafter evaluating the patient's joint pain when undergoing the same motion.
    Type: Application
    Filed: October 30, 2020
    Publication date: August 5, 2021
    Applicant: ORTHOTROPHIX, INC.
    Inventors: Yoshinari KUMAGAI, Dawn McGUIRE, Meghan MILLER, David ROSEN
  • Publication number: 20210236595
    Abstract: A method of alleviating joint pain in a patient comprising evaluating the patient's joint pain when undergoing motions associated stress to the joint, and injecting the patient with a peptide of SEQ ID No. 1, and thereafter evaluating the patient's joint pain when undergoing the same motion.
    Type: Application
    Filed: October 9, 2020
    Publication date: August 5, 2021
    Applicant: ORTHOTROPHIX, INC.
    Inventors: Yoshinari KUMAGAI, Dawn McGUIRE, Meghan MILLER, David ROSEN
  • Publication number: 20210216607
    Abstract: Digitally distributing media content using a distribution backbone system, including: receiving a request for media content from a client, the request including a client profile; performing inventory and analysis of source assets by iteratively progressing through the client profile to create output; performing a capability mapping in which a series of rules that allow the source assets to be mapped to the client profile; and planning a manufacturing process, which determines work items and execution steps from capabilities mapped in response to the request for media content from the client.
    Type: Application
    Filed: March 26, 2021
    Publication date: July 15, 2021
    Inventors: Rick Dinicola, David Rosen, Ryan Kido, Tatsuya Oiye, Keith Stevens
  • Publication number: 20210098546
    Abstract: An OLED display including a display panel and a color-correction component is described. A plurality of comparative display panels otherwise equivalent to the display panel but having one or more different optical thicknesses of OLED layers have a maximum white-point color shift from 0 to 45 degrees of WPCSC45 and a white-point axial efficiency of WPAEC. The plurality of comparative display panels defines a performance curve along a boundary of performance points. The OLED display and the display panel have respective maximum white-point color shifts from 0 to 45 degrees of WPCS45 and WPCS045 and respective white-point axial efficiencies of WPAE and WPAE0. WPCS045 and WPAE0 defines a performance point of the display panel to the right of the performance curve and WPCS45 and WPAE defines a performance point of the OLED display above or to the left of the performance curve. Methods of making the OLED display are described.
    Type: Application
    Filed: April 9, 2019
    Publication date: April 1, 2021
    Inventors: Nicholas C. Erickson, David G. Freier, Robert L. Brott, Bing Hao, David A. Rosen, Stephen M. Menke, Bert T. Chien, Song Taek Lee, Encai Hao, Zhaohui Yang, Albert I. Everaerts, Yongshang Lu, William Blake Kolb, Keith R. Bruesewitz, Adam D. Haag, Sun-Yong Park, Timothy J. Nevitt (Deceased), Brianna N. Wheeler, Jody L. Peterson, Gilles J. Benoit
  • Publication number: 20210090535
    Abstract: A method implemented by a determination engine is provided. The determination engine receives a media dataset comprising target piece music information, target piece audience information, corpus music information, corpus audience information, and corpus preference data. The determination engine determines a subset of the corpus music and preference information and determines at least one surprise factor of the subset of the corpus music and preference information across features at one of a plurality of orders. The determination engine learns a model that estimates a likelihood that time-varying surprise trends across the features achieves a preference level. The determination engine determines at least one surprise factor of the target piece music information across the features at the one of the plurality of orders and predicts, using the model, preference information using the time-varying surprise trends for the target piece music information across the features.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 25, 2021
    Applicant: Secret Chord Laboratories, Inc.
    Inventors: Scott Miles, David Rosen, Shaun Barry
  • Patent number: 10953333
    Abstract: Embodiments of a community-integrated smart playground of this disclosure and a method of its use include tracking geo-specific play data, populating a queue of digital notices, displaying one or more of the digital notices on a mobile device as a user plays on the playground and progresses through a virtual game dependent upon the playground activity, and producing revenue for the playground through the display or use of the digital notices. The playground includes at least one physical play structure containing a computer-readable identification tag, the at least one physical play structure representing a physical play activity. The virtual game may be non-analogous to the physical play but game progress is determined by the physical play. The system and method of its use may be executed by at least one mobile device having at least one microprocessor in network communication with the computer-readable identification tag and including associated software.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: March 23, 2021
    Assignee: Biba Ventures, Inc.
    Inventors: Michael David Rosen, Byron Joshua Seef, Matthew Herbert Toner
  • Patent number: 10849958
    Abstract: Knee pain evaluation and management is carried out via intra-articular injections into a patient suffering from knee pain with the injection being comprised of water and a particularly defined peptide. After injection, knee pain is evaluated using a pain subscale such as Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) or Knee injury and Osteoarthritis Outcome Score (KOOS).
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: December 1, 2020
    Assignee: ORTHOTROPHIX, INC.
    Inventors: Yoshinari Kumagai, Dawn McGuire, Meghan Miller, David Rosen
  • Patent number: 10849957
    Abstract: Making an initial evaluation of patient's joint pain when undergoing motions associated stress to the joint such as going up and down stairs, and injecting the patient with a peptide of SEQ ID No. 1, and thereafter evaluating the patient's joint pain when undergoing the same motion is disclosed.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: December 1, 2020
    Assignee: ORTHOTROPHIX, INC.
    Inventors: Yoshinari Kumagai, Dawn McGuire, Meghan Miller, David Rosen
  • Patent number: D929497
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: August 31, 2021
    Assignee: ZEBRA PAPER CONVERTERS INC.
    Inventors: Rana Harrilal, David Rosen